Učitavanje...
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2020-08-01
|
| Serija: | Vaccines |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2076-393X/8/3/447 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|